Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause

This randomized clinical trial examines 52-week efficacy and safety of elinzanetant in treating moderate to severe vasomotor symptoms that are associated with menopause.

from JAMA Internal Medicine Online First https://ift.tt/CD8OGN6